Treatment of non-Hodgkin lymphoma with point-of-care manufactured CAR T cells: a dual institution, phase 1 trial.

ABSTRACT:

SUBMITTER: Ghobadi A 

PROVIDER: S-EPMC11925540 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature